These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8481565)

  • 1. Clinical trials in multiple sclerosis.
    Noseworthy JH
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):209-15. PubMed ID: 8481565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C
    Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract]   [Full Text] [Related]  

  • 4. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies].
    Pette M; Hartung HP; Toyka KV
    Nervenarzt; 1994 Apr; 65(4):271-4. PubMed ID: 8015636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Update: treatment of multiple sclerosis].
    Kümpfel T; Hohlfeld R
    MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic indications for acute episodes of multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis.
    Waubant E; Goodkin D
    Pathol Biol (Paris); 2000 Mar; 48(2):104-13. PubMed ID: 10815286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Apr; 67(4):277-82. PubMed ID: 8684505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive treatment in multiple sclerosis].
    Vermeulen M; Zegerius L; van Crevel H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract]   [Full Text] [Related]  

  • 15. Optic neuritis.
    Cantore WA
    Pa Med; 1996 Mar; 99 Suppl():96-8. PubMed ID: 8867004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of follow-up and evolution of multiple sclerosis].
    Couvreur G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1143-51. PubMed ID: 11787348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fampridine-SR for multiple sclerosis and spinal cord injury.
    Hayes KC
    Expert Rev Neurother; 2007 May; 7(5):453-61. PubMed ID: 17492896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Summary of a round table discussion on the therapy of optic nerve neuritis].
    Aulhorn E; Hennerici M; Kampik A; Schmidt D; Schmidt R; Friedburg D
    Fortschr Ophthalmol; 1983; 80(5):369-70. PubMed ID: 6642355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.